Rockefeller Capital Management
GH icon

Rockefeller Capital Management’s Guardant Health GH Stock Holding History

Rockefeller Capital Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.77M Buy
18,444
+5,379
+41% +$585K ﹤0.01% 1234
2026
Q1 		$1.21M Buy
13,065
+1,447
+12% +$145K ﹤0.01% 1528
2025
Q4 		$1.19M Buy
11,618
+6,678
+135% +$597K ﹤0.01% 1481
2025
Q3 		$309K Sell
4,940
-7,862
-61% -$428K ﹤0.01% 2009
2025
Q2 		$666K Buy
+12,802
New +$572K ﹤0.01% 1467
2025
Q1 		– Sell
-16,357
Closed -$500K – 1690
2024
Q4 		$500K Buy
16,357
+2,757
+20% +$77.6K ﹤0.01% 1473
2024
Q3 		$312K Sell
13,600
-3,461
-20% -$98K ﹤0.01% 1535
2024
Q2 		$493K Sell
17,061
-8,242
-33% -$192K ﹤0.01% 1431
2024
Q1 		$522K Buy
25,303
+5,810
+30% +$125K ﹤0.01% 1457
2023
Q4 		$527K Sell
19,493
-834
-4% -$21.9K ﹤0.01% 1329
2023
Q3 		$602K Sell
20,327
-12,319
-38% -$433K ﹤0.01% 1242
2023
Q2 		$1.17M Sell
32,646
-3
-0% -$86 ﹤0.01% 1025
2023
Q1 		$765K Sell
32,649
-6,781
-17% -$194K ﹤0.01% 1175
2022
Q4 		$1.07M Buy
39,430
+6,626
+20% +$303K 0.01% 982
2022
Q3 		$1.76M Buy
32,804
+1,934
+6% +$99.3K 0.01% 795
2022
Q2 		$1.24M Buy
30,870
+7,847
+34% +$389K 0.01% 930
2022
Q1 		$1.52M Sell
23,023
-300
-1% -$20.5K 0.01% 903
2021
Q4 		$2.33M Buy
23,323
+8,282
+55% +$857K 0.01% 750
2021
Q3 		$1.88M Buy
15,041
+2,719
+22% +$323K 0.01% 777
2021
Q2 		$1.53M Buy
12,322
+2,071
+20% +$279K 0.01% 784
2021
Q1 		$1.56M Sell
10,251
-402
-4% -$60.8K 0.01% 652
2020
Q4 		$1.37M Buy
10,653
+701
+7% +$80.7K 0.01% 611
2020
Q3 		$1.11M Buy
9,952
+3,616
+57% +$331K 0.01% 574
2020
Q2 		$514K Buy
6,336
+1,035
+20% +$83.4K 0.01% 694
2020
Q1 		$369K Buy
5,301
+3,439
+185% +$264K ﹤0.01% 675
2019
Q4 		$146K Buy
1,862
+26
+1% +$1.87K ﹤0.01% 850
2019
Q3 		$117K Sell
1,836
-42
-2% -$3.7K ﹤0.01% 749
2019
Q2 		$162K Buy
+1,878
New +$143K ﹤0.01% 609

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Rockefeller Capital Management's GH Position: Q2 2026 in Review

Rockefeller Capital Management increased its Guardant Health (GH) stake by 41% in Q2 2026, buying an estimated $585K and bringing the position to 18,444 shares worth $2.77M. The position accounts for ﹤0.01% of the portfolio, ranked #1234.

Rockefeller Capital Management first reported a position in GH in Q2 2019 and has held it in 28 quarters since. 600 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Rockefeller Capital Management held 18,444 shares of Guardant Health worth $2.77M as of Q2 2026.
  • Rockefeller Capital Management bought 5,379 Guardant Health shares in Q2 2026, an estimated $585K.
  • Guardant Health made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #1234 holding.
  • Rockefeller Capital Management first reported a position in Guardant Health in Q2 2019 and has held it in 28 quarters since.
  • 600 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.